StonvexLoading…
StonvexStonvexStonvexCore line items from FCFS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.05B | $464.83M | $1.67B | $1.17B | $756.18M |
Operating Income | Not available | $145.13M | $447.56M | $304.77M | $192.30M |
Net Income | Not available | $107.70M | $330.38M | $226.20M | $59.80M |
EPS (Diluted) | $2.36 | $2.43 | $7.42 | $5.07 | $3.21 |
Total Assets | Not available | $5.36B | $5.30B | $5.18B | $4.51B |
Total Liabilities | Not available | $3.06B | $3.02B | $2.98B | $2.37B |
Cash & Equivalents | Not available | $130.74M | $125.20M | $130.24M | $101.47M |
Free Cash Flow OCF − CapEx | Not available | Not available | $531.04M | Not available | Not available |
Shares Outstanding | Not available | 44.25M | 43.98M | 44.60M | 44.67M |